Related Experiment Video
Updated: Dec 10, 2025
In Vitro Colony Assays for Characterizing Tri-potent Progenitor Cells Isolated from the Adult Murine Pancreas
Published on: June 10, 2016
Therapeutic Potentials of MicroRNAs for Curing Diabetes Through Pancreatic β-Cell Regeneration or Replacement
Muhammad Waseem Ghani1, Ye Li1, Hammad Ghani2
1From the Department of Animal Science and Medicine, College of Coastal Agricultural Sciences, Guangdong Ocean University, Zhanjiang, China.
Abstract:
MicroRNAs are a type of noncoding RNAs that regulates the expression of target genes at posttranscriptional level. MicroRNAs play essential roles in regulating the expression of different genes involved in pancreatic development, β-cell mass maintenance, and β-cell function. Alteration in the level of miRNAs involved in β-cell function leads to the diabetes. Being an epidemic, diabetes threatens the life of millions of patients posing a pressing demand for its urgent resolve. However, the currently available therapies are not substantial to cure the diabetic epidemic. Thus, researchers are trying to find new ways to replenish the β-cell mass in patients with diabetes. One promising approach is the in vivo regeneration of β-cell mass or increasing the efficiency of β-cell function. Another clinical strategy is the transplantation of in vitro developed β-like cells. Owing to their role in pancreatic β-cell development, maintenance, functioning and their involvement in diabetes, overexpression or attenuation of different miRNAs can cause β-cell regeneration in vivo or can direct the differentiation of various kinds of stem/progenitor cells to β-like cells in vitro. Here, we will summarize different strategies used by researchers to investigate the therapeutic potentials of miRNAs, with focus on miR-375, for curing diabetes through β-cell regeneration or replacement.
Insights
MicroRNAs regulate gene expression and are crucial for pancreatic beta-cell function. Manipulating microRNAs offers promising therapeutic strategies for diabetes by regenerating beta-cells or developing replacements.
Area of Science:
- Biochemistry
- Molecular Biology
- Endocrinology
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression at the posttranscriptional level.
- These noncoding RNAs play critical roles in pancreatic development, beta-cell mass maintenance, and function.
- Dysregulation of miRNAs is implicated in the pathogenesis of diabetes, a global health epidemic.
Purpose of the Study:
- To summarize therapeutic strategies utilizing miRNAs for diabetes treatment.
- To explore the potential of miRNAs in beta-cell regeneration and replacement therapies.
- To focus on the specific role of miR-375 in these regenerative approaches.
Main Methods:
- Review of current research on miRNA function in pancreatic beta-cells.
- Analysis of strategies for in vivo beta-cell regeneration.
- Evaluation of methods for in vitro development of beta-like cells from stem/progenitor cells.
- Focus on manipulating miRNA levels (overexpression or attenuation) for therapeutic benefit.
Main Results:
- miRNAs are essential for normal pancreatic beta-cell development and function.
- Altered miRNA levels are directly linked to diabetes development.
- Modulating specific miRNAs, like miR-375, shows potential for beta-cell regeneration in vivo.
- miRNAs can guide stem/progenitor cell differentiation into functional beta-like cells in vitro.
Conclusions:
- MicroRNAs represent a promising therapeutic target for managing and potentially curing diabetes.
- Targeted manipulation of miRNAs offers novel strategies for beta-cell restoration and replacement.
- Further research into miRNA-based therapies, particularly miR-375, is warranted for diabetes treatment.
Related Concept Videos
01:22iPS Cell Differentiation
01:23Tissue Renewal without Stem Cells
However, failure of such a system...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...